FEATURED NEWS
Lab News
Laboratories stand ready if needed for monkeypox threat
May 26, 2022 -- It remains to be seen whether the much-covered monkeypox scare will turn out to be a significant crisis, a moderate concern of the likes of Zika, or just a media story of exaggerated importance. Bruce Carlson of Kalorama Information offers a perspective. Read More
AACC lobbies against greater regulation of lab-developed tests
May 26, 2022 -- The American Association for Clinical Chemistry (AACC) is urging Congress to not include a bill to mandate greater regulatory oversight of laboratory-developed tests as part of its omnibus U.S. Food and Drug Administration (FDA) user fee legislation. Read More
Seegene unveils strategy for $12 COVID-19 PCR tests
May 26, 2022 -- South Korea-based molecular diagnostics company Seegene has unveiled a global initiative for preemptive and routine COVID-19 PCR testing that the company hopes will cost just $12 per test. Read More
Certific launches remote UTI testing platform
May 26, 2022 -- Certific has launched a digital screening service for urinary tract infection (UTI) testing that guides patients through simple certified procedures. Read More
Sysmex Inostics launches AML panel
May 25, 2022 -- Sysmex Inostics has launched a panel of tests to detect mutations of the three most prevalent genes in acute myeloid leukemia (AML): IDH1, IDH2, and NPM1. Read More
Hologic gets CE Mark for fusion transplant pathogen tests
May 25, 2022 -- Hologic has announced that it has received the CE Mark for two new molecular assays that monitor for Epstein-Barr virus (EBV) and BK virus (BKV) in transplant patients. Read More
OptraScan wins patent for digital pathology AI technology
May 25, 2022 -- OptraScan has received a U.S. patent for technology on its OS-SiA digital pathology scanner, which is able to scan, index, and analyze pathological samples simultaneously. Read More
Illumina wins new indication for TruSight Oncology in Europe
May 25, 2022 -- Illumina has received a new pan-cancer companion diagnostic (CDx) indication to the CE Mark for its TruSight Oncology Comprehensive (EU) test kit, which is currently being sold in Europe. Read More
Biomarker data improves CT lung cancer screening's bottom line
May 24, 2022 -- The cost-effectiveness of low-dose computed tomography (CT) for lung cancer screening is improved by adding a plasma-based biomarker into the clinical evaluation, according to a study published May 24 in JAMA Network Open. Read More
Indica gets CE-IVD Mark for prostate cancer screening tool
May 23, 2022 -- Computational pathology software company Indica Labs has secured a CE-IVD Mark for its Halo Prostate AI deep learning prostate cancer screening software. Read More
Conferences
American Diabetes Association (ADA) Scientific Sessions
June 3-7
New Orleans, Louisiana United States
American Society of Clinical Oncology Annual Meeting
June 3-7
Chicago, Illinois United States
International Liver Congress
June 22-26
London United Kingdom
Connect
LabPulse on LinkedIn
LabPulse on Facebook
LabPulse on Twitter
Latest Tweets
Webinars/Videos